Live symbol workspace

ALGN market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Current $170.62

Trend Flat

Sentiment Neutral

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support

$162.09

Resistance

$179.15

Volume & Momentum

Volume

Weak

0.8x avg

Momentum

0%

Weak

Technical Context

Current price

$170.62

RSI context

50

Market Sentiment

50

Neutral

Stock Metrics

Daily Vol

0%

VIX Est

20

Weekly

0%

Asset Intelligence Dossier

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

33%

▲ 3.3 pts vs previous week

Avg confidence across 9 calls in the last 7 days

What sources say

Bullish 1 article

3 Reasons to Avoid ALGN and 1 Stock to Buy Instead

Insider Trading

Refreshing insider trades from FinViz…

Technical Observations

Refreshing technical observations from FinViz...

ALGN News Intelligence (2 articles)

AI-curated news influencing ALGN price, sentiment, and trend

Explore All ALGN News with AI Analysis

Economy

2 hours, 44 minutes ago

3 Reasons to Avoid ALGN and 1 Stock to Buy Instead

Over the past six months, Align Technology has been a great trade, beating the S&P 500 by 5.5%. Its stock …

Impact on ALGN: Potentially positive price action expected

Analysis of stock market developments showing bullish sentiment. Medium (60%)

View full analysis →

Yahoo Finance 60% confidence

Economy

3 months ago

Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know

A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial …

Impact on ALGN: The escalating U.S.-Iran conflict and associated policy deadlines are causing a risk-off …

Shares of Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell are declining due to escalating U.S.-Iran … High (80%)

View full analysis →

Yahoo Finance 80% confidence